NPPB and Alzheimer disease: Interestingly, a post‐mortem AD patient is associated with low BNP in the CSF8; thus, the reduction of brain BNP may accelerate the development of neuroinflammation, neurodegeneration, oxidative stress and BBB dysfunction.145